Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Early life exposures and development of allergic disease in infants with familial risk: results from ongoing probiotic intervention trials

Turta Olli; Rautava Samuli; Puisto Reetta; Isolauri Erika

Early life exposures and development of allergic disease in infants with familial risk: results from ongoing probiotic intervention trials

Turta Olli
Rautava Samuli
Puisto Reetta
Isolauri Erika

Tätä artikkelia/julkaisua ei ole tallennettu UTUPubiin. Julkaisun tiedoissa voi kuitenkin olla linkki toisaalle tallennettuun artikkeliin / julkaisuun.

Wiley
doi:10.1111/apa.16518
URI
https://onlinelibrary.wiley.com/doi/10.1111/apa.16518
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2022091258721
Tiivistelmä

Aim: We search revision of risk determinants of the ongoing allergy epidemic.

Methods: 433 children born to mothers with allergic disease or sensitization were selected from the three ongoing probiotic intervention trials for this case-control study. Children who developed atopic eczema or food allergy, had positive skin prick test results or had been prescribed inhaled corticosteroids by the age of two years were identified as cases (n=231) while children without allergic manifestations were the healthy controls (n=202). The data on early environmental exposures were collected from prospectively documented study records. The statistical analyses were adjusted for potential confounders.

Results: Determinants associated with the increased risk of atopic eczema were lower maternal prepregnancy BMI (aOR 0.15, 95% CI: 0.037 – 0.54) and maternal intrapartum antibiotic treatment (aOR 2.21, 95% CI 1.20 – 4.10), the latter also linked to obstructive respiratory symptoms (aOR 3.87, 95% CI 1.07 – 14.06). The risk of allergic sensitization was associated with lower maternal prepegnancy BMI (aOR 0.18, 95% CI 0.43 – 0.79) and intrapartum antibiotic treatment (aOR 2.13, 95% CI 1.07 – 4.22).

Conclusion: Based on our demonstrations, interventions such as personalized diets, can be optimized for specific subgroups and definite risk periods.

Kokoelmat
  • Rinnakkaistallenteet [19207]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste